Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide

British Journal of Pharmacology

Volumn 141, Issue 7, 2004, Pages 1118-1130

  Price, Theodore J ^a   Patwardhan, Amol ^a   Akopian, Armen N ^a   Hargreaves, Kenneth M ^a   Flores, Christopher M ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Johnson Johnson P   (United States)

Author keywords

Anandamide; Arachidonyl 2 chloroethylamide; Calcitonin gene related peptide; Cannabinoid; n arachidonoyl dopamine; Pain; Sensory neuron; Transient receptor potential; Trigeminal ganglion; Vanilloid

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ANANDAMIDE; ARACHIDONIC ACID DERIVATIVE; ARACHIDONYL 2 CHLOROETHYLAMIDE; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CAPSAICIN; CAPSAZEPINE; N ARACHIDONOYLDOPAMINE; PROSTAGLANDIN E; PROTEIN KINASE INHIBITOR; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; EVOKED RESPONSE; GANGLION; IC 50; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

AMINOBUTYRIC ACIDS; ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM CHANNELS; CAPSAICIN; DINOPROSTONE; DITERPENES; DOPAMINE; GANGLIA, SPINAL; MALE; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, DRUG; STAUROSPORINE; TRIGEMINAL GANGLION; TRPC CATION CHANNELS; TRPV CATION CHANNELS;

EID: 2342626531     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705711     Document Type: Article

References (71)

1. AFRAH, A.W., FISKA, A., GJERSTAD, J., GUSTAFSSON, H., TJOLSEN, A., OLGART, L., STILLER, C.O., HOLE, K. & BRODIN, E. (2002), Spinal substance P release in vivo during the induction of long-term potentiation in dorsal horn neurons. Pain, 96, 49-55.
2. AGOPYAN, N., LI, L., YU, S. & SIMON, S.A. (2003). Negatively charged 2- and 10-micron particles activate vanilloid receptors, increase cAMP, and induce cytokine release. Toxicol. Appl. Pharmacol., 186, 63-76.
3. AHLUWALIA, J., URBAN, L., BEVAN, S. & NAGY, I. (2003a). Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci., 17, 2611-2618.
4. AHLUWALIA, J., YAQOOB, M., URBAN, L., BEVAN, S. & NAGY, I. (2003b). Activation of capsaicin-sensitive primary sensory neurones induces anandamide production and release. J. Neurochem., 84, 585-591.
5. BENNETT, A.D., CHASTAIN, K.M. & HULSEBOSCH, C.E. (2000). Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain, 86, 163-175.
6. BERG, K.A., CLARKE, W.P., SAILSTAD, C., SALTZMAN, A. & MAAYANI, S. (1994). Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems. Mol. Pharmacol., 46, 477-484.
7. BHAVE, G., ZHU, W., WANG, H., BRASIER, D.J., OXFORD, G.S. & GEREAU, R.W.T. (2002). cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Neuron, 35, 721-731.
8. BRAIN, S.D. & WILLIAMS, T.J. (1985). Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. Br. J. Pharmacol., 86, 855-860.
9. BRAIN, S.D., WILLIAMS, T.J., TIPPINS, J.R., MORRIS, H.R. & MACINTYRE, I. (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature, 313, 54-56.
10. BRIDGES, D., RICE, A.S., EGERTOVA, M., ELPHICK, M.R., WINTER, J. & MICHAEL, G.J. (2003). Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience, 119, 803-812.
11. CALIGNANO, A., LA RANA, G., GIUFFRIDA, A. & PIOMELLI, D. (1998). Control of pain initiation by endogenous cannabinoids. Nature, 394, 277-281.
12. CALIGNANO, A., LA RANA, G. & PIOMELLI, D. (2001). Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur. J. Pharmacol., 419, 191-198.
13. CATERINA, M.J., LEFFLER, A., MALMBERG, A.B., MARTIN, W.J., TRAFTON, J., PETERSEN-ZEITZ, K.R., KOLTZENBURG, M., BASBAUM, A.I. & JULIUS, D. (2000). Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science, 288, 306-313.
14. CATERINA, M.J., SCHUMACHER, M.A., TOMINAGA, M., ROSEN, T.A., LEVINE, J.D. & JULIUS, D. (1997). The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature, 389, 816-824.
15. DE PETROCELLIS, L., HARRISON, S., BISOGNO, T., TOGNETTO, M., BRANDI, I., SMITH, G.D., CREMINON, C., DAVIS, J.B., GEPPETTI, P. & DI MARZO, V. (2001). The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J. Neurochem., 77, 1660-1663.
16. DENDA, M., FUZIWARA, S., INOUE, K., DENDA, S., AKAMATSU, H., TOMITAKA, A. & MATSUNAGA, K. (2001). Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem. Biophys. Res. Commun., 285, 1250-1252.
17. DISTLER, C., RATHEE, P.K., LIPS, K.S., OBREJA, O., NEUHUBER, W. & KRESS, M. (2003). Fast Ca2+-induced potentiation of heat-activated ionic currents requires cAMP/PKA signaling and functional AKAP anchoring. J. Neurophysiol., 89, 2499-2505.
18. DYMSHITZ, J. & VASKO, M.R. (1994). Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci. Lett., 167, 128-132.
19. EVANS, A.R., NICOL, G.D. & VASKO, M.R. (1996). Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons. Brain Res., 712, 265-273.
20. FARQUHAR-SMITH, W.P., JAGGAR, S.I. & RICE, A.S. (2002), Attenuation of nerve growth factor-induced visceral hyperalgesia via cannabinoid CB(1) and CB(2)-like receptors. Pain, 97, 11-21.
21. FARQUHAR-SMITH, W.P. & RICE, A.S. (2001). Administration of endocannabinoids prevents a referred hyperalgesia associated with inflammation of the urinary bladder. Anesthesiology, 94, 507-513 discussion 6A.
22. FOX, A., KESINGLAND, A., GENTRY, C., MCNAIR, K., PATEL, S., URBAN, L. & JAMES, I. (2001). The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91-100.
23. GAMSE, R. & SARIA, A. (1986). Nociceptive behavior after intrathecal injections of substance P, neurokinin A and calcitonin gene-related peptide in mice. Neurosci. Lett., 70, 143-147.
24. GARCIA-NICAS, E., LAIRD, J.M. & CERVERO, F. (2001). Vasodilatation in hyperalgesic rat skin evoked by stimulation of afferent A beta-fibers: further evidence for a role of dorsal root reflexes in allodynia. Pain, 94, 283-291.
25. GOVER, T.D., KAO, J.P. & WEINREICH, D. (2003). Calcium signaling in single peripheral sensory nerve terminals. J. Neurosci., 23, 4793-4797.
26. GU, Q., KWONG, K. & LEE, L.Y. (2003). Ca2+ transient evoked by chemical stimulation is enhanced by PGE2 in vagal sensory neurons: role of cAMP/PKA signaling pathway. J. Neurophysiol., 89, 1985-1993.
27. GUO, A., VULCHANOVA, L., WANG, J., LI, X. & ELDE, R. (1999). Immunocytochemical localization of the vanilloid receptor 1 (VR1): relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur. J. Neurosci., 11, 946-958.
28. HAMMOND, D.L. & RUDA, M.A. (1991). Developmental alterations in nociceptive threshold, immunoreactive calcitonin gene-related peptide and substance P, and fluoride-resistant acid phosphatase in neonatally capsaicin-treated rats. J. Comp. Neurol., 312, 436-450.
29. HINGTGEN, C.M., WAITE, K.J. & VASKO, M.R. (1995). Prostaglandins facilitate peptide release from rat sensory neurons by activating the adenosine 3′,5′-cyclic monophosphate transduction cascade. J. Neurosci., 15, 5411-5419.
30. HOHMANN, A.G. (2002). Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem. Phys. Lipids, 121, 173-190.
31. HUANG, S.M., BISOGNO, T., TREVISANI, M., AL-HAYANI, A., DE PETROCELLIS, L., FEZZA, F., TOGNETTO, M., PETROS, T.J., KREY, J.F., CHU, C.J., MILLER, J.D., DAVIES, S.N., GEPPETTI, P., WALKER, J.M. & DI MARZO, V. (2002). An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. U.S.A., 99, 8400-8405.
32. IBRAHIM, M.M., DENG, H., ZVONOK, A., COCKAYNE, D.A., KWAN, J., MATA, H.P., VANDERAH, T.W., LAI, J., PORRECA, F., MAKRIYANNIS, A. & MALAN JR, T.P. (2003). Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc. Natl. Acad. Sci. U.S.A., 100, 10529-10533.
33. IIDA, T., MORIYAMA, T., KOBATA, K., MORITA, A., MURAYAMA, N., HASHIZUME, S., FUSHIKI, T., YAZAWA, S., WATANABE, T. & TOMINAGA, M. (2003). TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology, 44, 958-967.
34. IKEDA, H., HEINKE, B., RUSCHEWEYH, R. & SANDKUHLER, J. (2003). Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science, 299, 1237-1240.
35. INOUE, K., KOIZUMI, S., FUZIWARA, S., DENDA, S. & DENDA, M. (2002). Functional vanilloid receptors in cultured normal human epidermal keratinocytes. Biochem. Biophys. Res. Commun., 291, 124-129.
36. JANCSO, N., JANCSO-GABOR, A. & SZOLCSANYI, J. (1967). Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br. J. Pharmacol., 31, 138-151.
37. JENNINGS, E.A., VAUGHAN, C.W., ROBERTS, L.A. & CHRISTIE, M.J. (2003). The actions of anandamide on rat superficial medullary dorsal horn neurons in vitro. J. Physiol., 548, 121-129.
38. JI, R.R., SAMAD, T.A., JIN, S.X., SCHMOLL, R. & WOOLF, C.J. (2002). p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron, 36, 57-68.
39. JORDT, S.E., BAUTISTA, D.M., CHUANG, H.H., MCKEMY, D.D., ZYGMUNT, P.M., HOGESTATT, E.D., MENG, I.D. & JULIUS, D. (2004). Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature, 427, 260-265.
40. KHASABOVA, I.A., SIMONE, D.A. & SEYBOLD, V.S. (2002). Cannabinoids attenuate depolarization-dependent Ca2+ influx in intermediate-size primary afferent neurons of adult rats. Neuroscience. 115, 613-625.
41. KIM, H.T., PARK, S.K., LEE, S.E., CHUNG, J.M. & LEE, D.H. (2001). Non-noxious A fiber afferent input enhances capsaicin-induced mechanical hyperalgesia in the rat. Pain, 94, 169-175.
42. KO, M.C. & WOODS, J.H. (1999). Local administration of delta9-tetrahydrocannabinol attenuates capsaicin-induced thermal nociception in rhesus monkeys: a peripheral cannabinoid action. Psychopharmacology (Berl.), 143, 322-326.
43. LIU, L., OORTGIESEN, M., LI, L. & SIMON, S.A. (2001). Capsaicin inhibits activation of voltage-gated sodium currents in capsaicin-sensitive trigeminal ganglion neurons. J. Neurophysiol., 85, 745-758.
44. LIU, L., SZALLASI, A. & SIMON, S.A. (1998). A non-pungent resiniferatoxin analogue, phorbol 12-phenylacetate 13 acetate 20-homovanillate, reveals vanilloid receptor subtypes on rat trigeminal ganglion neurons. Neuroscience, 84, 569-581.
45. LOPSHIRE, J.C. & NICOL, G.D. (1998). The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: whole-cell and single-channel studies. J. Neurosci., 18, 6081-6092.
46. MACCARRONE, M., DI RIENZO, M., BATTISTA, N., GASPERI, V., ROSSI, A. & FINAZZI-AGRO, A. (2003). The endocannabinoid system in human keratinocytes. Evidence that anandamide inhibits epidermal differentiation through CB1 receptor-dependent inhibition of protein kinase C, activating protein-1 and transglutaminase. J. Biol. Chem., 278, 33896-33903.
47. MACIVER, M.B. & TANELIAN, D.L. (1993). Structural and functional specialization of A delta and C fiber free nerve endings innervating rabbit corneal epithelium. J. Neurosci., 13, 4511-4524.
48. MALAN JR, T.P., IBRAHIM, M.M., DENG, H., LIU, Q., MATA, H.P., VANDERAH, T., PORRECA, F. & MAKRIYANNIS, A. (2001). CB2 cannabinoid receptor-mediated peripheral antinociception. Pain, 93, 239-245.
49. MALAN, T.P., IBRAHIM, M.M., VANDERAH, T.W., MAKRIYANNIS, A. & PORRECA, F. (2002). Inhibition of pain responses by activation of CB(2) cannabinoid receptors. Chem. Phys. Lipids, 121, 191-200.
50. MATSUDA, L.A., LOLAIT, S.J., BROWNSTEIN, M.J., YOUNG, A.C. & BONNER, T.I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
51. MCMAHON, S.B. (1996). NGF as a mediator of inflammatory pain. Philos. Trans. R. Soc. Lond. B Biol. Sci., 351, 431-440.
52. MUNRO, S., THOMAS, K.L. & ABU-SHAAR, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
53. NORTHAM, W.J. & JONES, D.J. (1984). Comparison of capsaicin and substance P induced cyclic AMP accumulation in spinal cord tissue slices. Life Sci., 35, 293-302.
54. PRICE, T.J., HELESIC, G., PARGHI, D., HARGREAVES, K.M. & FLORES, C.M. (2003). The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience. 120, 155-162.
55. RICE, A.S., FARQUHAR-SMITH, W.P. & NAGY, I. (2002). Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostagland. Leukotr. Essent. Fatty Acids, 66, 243-256.
56. RICHARDSON, J.D., KILO, S. & HARGREAVES, K.M. (1998). Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors. Pain, 75, 111-119.
57. ROSS, R.A., COUTTS, A.A., MCFARLANE, S.M., ANAVI-GOFFER, S., IRVING, A.J., PERTWEE, R.G., MACEWAN, D.J. & SCOTT, R.H. (2001). Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception. Neuropharmacology, 40, 221-232.
58. RUKWIED, R., WATKINSON, A., MCGLONE, F. & DVORAK, M. (2003). Cannabinoid agonists attenuate capsaicin-induced responses in human skin. Pain, 102, 283-288.
59. SEABROOK, G.R., SUTTON, K.G., JAROLIMEK, W., HOLLINGWORTH, G.J., TEAGUE, S., WEBB, J., CLARK, N., BOYCE, S., KERBY, J., ALI, Z., CHOU, M., MIDDLETON, R., KACZOROWSKI, G. & JONES, A.B. (2002). Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3- methoxyphenylacetate ester) iodo-resiniferatoxin. J. Pharmacol. Exp. Ther., 303, 1052-1060.
60. SMART, D., GUNTHORPE, M.J., JERMAN, J.C, NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227-230.
61. SOUTHALL, M.D., LI, T., GHARIBOVA, L.S., PEI, Y., NICOL, G.D. & TRAVERS, J.B. (2003). Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes. J. Pharmacol. Exp. Ther., 304, 217-222.
62. SUN, R.Q., LAWAND, N.B. & WILLIS, W.D. (2003). The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain, 104, 201-208.
63. SZALLASI, A., BIRO, T., SZABO, T., MODARRES, S., PETERSEN, M., KLUSCH, A., BLUMBERG, P.M., KRAUSE, J.E. & STERNER, O. (1999). A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors. Br. J. Pharmacol., 126, 1351-1358.
64. SZOKE, E., CZEH, G., SZOLCSANYI, J. & SERESS, L. (2002a). Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. Neuroscience, 115, 805-814.
65. SZOKE, E., SERESS, L. & SZOLCSANYI, J. (2002b). Neonatal capsaicin treatment results in prolonged mitochondrial damage and delayed cell death of B cells in the rat trigeminal ganglia. Neuroscience, 113, 925-937.
66. ULRICH-LAI, Y.M., FLORES, C.M., HARDING-ROSE, C.A., GOODIS, H.E. & HARGREAVES, K.M. (2001). Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from rat trigeminal ganglion: evidence for intraganglionic neurotransmission. Pain, 91, 219-226.
67. URBAN, L., CAMPBELL, E.A., PANESAR, M., PATEL, S., CHAUDHRY, N., KANE, S., BUCHHEIT, K., SANDELLS, B. & JAMES, I.F. (2000). In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue. Pain, 89, 65-74.
68. WALKER, J.M., HOHMANN, A.G., MARTIN, W.J., STRANGMAN, N.M., HUANG, S.M. & TSOU, K. (1999). The neurobiology of cannabinoid analgesia. Life Sci., 65, 665-673.
69. WALKER, J.M., STRANGMAN, N.M. & HUANG, S.M. (2001). Cannabinoids and pain. Pain Res. Manag., 6, 74-79.
70. WOOD, J.N., COOTE, P.R., MINHAS, A., MULLANEY, I., MCNEILL, M. & BURGESS, G.M. (1989). Capsaicin-induced ion fluxes increase cyclic GMP but not cyclic AMP levels in rat sensory neurones in culture. J. Neurochem., 53, 1203-1211.
71. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SORGARD, M., DI MARZO, V., JULIUS, D. & HOGESTATT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-457.